Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGL | P35573 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 8/20 | 0.38 |
| ▸ | MGAM | O43451 | 3/20 | 0.38 |
| ▸ | SI | P14410 | 3/20 | 0.38 |
| ▸ | GBA1 | P04062 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LCT | P09848 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
| ▸ | GBA2 | Q9HCG7 | 8/20 | 0.31 |
| ▸ | UGCG | Q16739 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12337293 | 1.00 | AGL (0.39) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL5441422 | 0.89 | AGL (0.46) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL18874061 | 0.83 | GAA (0.38) | GAA | |
| SCHEMBL13662010 | 0.83 | GAA (0.38) | GAA | |
| SCHEMBL18820448 | 0.83 | AGL (0.39) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL24402950 | 0.83 | AGL (0.39) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL24402941 | 0.83 | AGL (0.39) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL23732000 | 0.78 | AGL (0.40) | AGLGAAMGAMSIGBA1 | |
| SCHEMBL18513254 | 0.77 | HSD11B1 (0.38) | GAA | |
| SCHEMBL20757950 | 0.77 | HSD11B1 (0.38) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022090481-A1 | SUBSTITUTED 1H-PYRAZOLO[4,3-C]PYRIDINES AND DERIVATIVES AS EGFR INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-05-05 | — | — | WO | disclosed |